Custom Antibody Services Market to Grow at a CAGR of 9.5% Through 2033
The Global Custom Antibody Services Market is projected to reach USD 1,361 million by 2033, up from USD 549 million in 2023, reflecting a compound annual growth rate (CAGR) of 9.5% during the forecast period from 2024 to 2033. This growth is driven by several factors, including increased research activities and funding investments for antibody development, the rising use of custom antibodies in precision medicine, and their application in biomarker identification and validation. Key challenges in the market include the high costs and complexities associated with antibody development and the presence of alternative antibodies.
Recent developments, such as strategic partnerships and increased public-private collaborations, are enhancing market dynamics and fostering innovation. For instance, the U.S. market alone is anticipated to grow significantly, driven by substantial funding for antibody research and a robust client base. The Asia-Pacific region is also expected to register the highest growth rate due to increasing investments and the rising prevalence of chronic diseases.
Key Takeaways
- The market size is projected to reach USD 1361 million by 2033, with a CAGR of 9.5% from 2024-2033.
- Monoclonal antibodies dominated in 2023, holding 51.7% of the market share due to crucial medical applications.
- Antibody development services secured 55.3% market share in 2023, driven by rising demand for specific antibodies.
- The rabbit segment held over 49.5% market share in 2023, attributed to high specificity and advanced immunization technologies.
- Infectious diseases were the top application, leading with a 28.3% market share in 2023, driven by the COVID-19 pandemic.
- Academic and research institutes were the major end-users, dominating the market in 2023.
- The rising demand for personalized medicine is a key driver, revolutionizing patient care and increasing the need for custom antibodies.
- High costs and technical challenges in antibody production present significant challenges, limiting accessibility for smaller research institutions.
- Advances in antibody engineering and technologies offer notable opportunities, enhancing antibody specificity and affinity, driving market growth.
- An emerging trend is the shift towards therapeutic antibodies, focusing on monoclonal antibodies for various clinical applications.
- North America was the regional leader in 2023, holding over 45% market share and reaching a market value of USD 269 million.
Get Sample PDF Report: https://market.us/report/custom-antibody-services-market/request-sample/
Custom Antibody Services Market Key Segments
Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Other Types
Service
- Antibody Development
- Antibody Production & Purification
- Antibody Fragmentation
- Antibody Labeling
- Other Services
Source
- Mice
- Rabbit
- Other Sources
Application
- Oncology
- Infectious Diseases
- Neurology
- Immunology
- Cardiovascular Diseases
- Other Applications
End-user
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Hospitals And Clinics
- Other End-Users
Key Regions
- North America (The US, Canada, Mexico)
- Western Europe (Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, Rest of Western Europe)
- Eastern Europe (Russia, Poland, The Czech Republic, Greece, Rest of Eastern Europe)
- APAC (China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Rest of APAC)
- Latin America (Brazil, Colombia, Chile, Argentina, Costa Rica, Rest of Latin America)
- Middle East & Africa (Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, Rest of MEA)
Buy Directly: https://market.us/purchase-report/?report_id=12275
Key Players Analysis
Abcam plc specializes in providing custom antibody services tailored to various research and diagnostic needs. Their comprehensive offerings include antibody generation, selection, characterization, and manufacturing. Abcam employs proprietary RabMAb technology to produce high-quality rabbit monoclonal antibodies, which are crucial for challenging targets like post-translationally modified proteins and transmembrane proteins. The company’s approach integrates technical expertise with flexible commercial strategies, ensuring high-performance reagents and seamless transitions from research to clinical applications. Their partnerships extend globally, supporting diagnostic and therapeutic developments.
Thermo Fisher Scientific Inc. offers extensive custom antibody services designed to accelerate research and therapeutic development. Their services encompass the entire antibody development process, from initial design and production to validation and large-scale manufacturing. Thermo Fisher utilizes advanced technologies and platforms, such as their proprietary Invitrogen and Pierce brands, to ensure high specificity and affinity of antibodies. Their solutions are widely used in various fields, including oncology, immunology, and neuroscience, providing researchers with reliable tools for innovative discoveries and diagnostics.
Creative Diagnostics is a key player in the custom antibody services sector, providing a wide range of tailored solutions for antibody production and development. Their services include monoclonal and polyclonal antibody generation, hybridoma development, and antibody purification. Creative Diagnostics also offers conjugation and labeling services to meet specific research needs. They emphasize flexibility and customization, ensuring that each project is aligned with the client’s unique requirements. This enables researchers to achieve high-quality, reproducible results across various applications, from basic research to clinical diagnostics.
Bio-Rad Laboratories Inc. provides comprehensive custom antibody services aimed at facilitating advanced research and diagnostic applications. Their offerings include antibody development, production, and purification, with a focus on high specificity and reproducibility. Bio-Rad’s technologies support a wide array of research areas, including genomics, proteomics, and cell biology. They employ innovative techniques such as phage display and hybridoma technology to develop antibodies that meet stringent quality standards. Bio-Rad’s extensive portfolio ensures researchers have access to reliable reagents for their scientific endeavors.
Kaneka Eurogentec S.A. offers specialized custom antibody services with a strong emphasis on quality and precision. Their services include the development of monoclonal and polyclonal antibodies, antibody engineering, and production. Eurogentec’s proprietary technologies and platforms enable the generation of antibodies with high affinity and specificity, suitable for various research and diagnostic applications. They cater to the needs of pharmaceutical and biotechnology companies, providing support from early discovery phases to large-scale production. Eurogentec’s commitment to excellence ensures the delivery of high-performance antibodies tailored to specific project requirements.
Custom Antibody Services Market Key Players:
- Abcam plc
- Thermo Fisher Scientific Inc.
- Creative Diagnostics
- Bio-Rad Laboratories Inc
- Kaneka Eurogentec S.A.
- YenZym Antibodies LLC.
- Labcorp Drug Development
- LifeSpan BioSciences Inc
- GenScript
Custom Antibody Services Market Report Scope >> Market Value (2023): USD 549 Million || Forecast Revenue (2033): USD 1361 Million || CAGR (2024-2033): 9.5% || Base Year Estimation: 2023 || Historic Period: 2019-2022 || Forecast Period: 2024-2033.
Inquire More about report: https://market.us/report/custom-antibody-services-market/#inquiry
About Market.US
Market.US is renowned for its comprehensive market research and analysis, providing customized and syndicated reports to a global clientele. Specializing in a variety of sectors, they offer strategic insights and detailed market forecasts, assisting businesses in making informed decisions. With a focus on innovation and accuracy, Market.US supports clients in over 126 countries, and maintains a strong repeat customer rate, underscoring their commitment to quality and client satisfaction. Their team excels in delivering exceptional research services, ensuring that no detail is overlooked in any target market.
Contact Details
Market.us (Powered By Prudour Pvt. Ltd.)
Contact No: +1 718 618 4351.
Email: inquiry@market.us
Blog: https://medicalmarketreport.com/
View More Trending Reports
Medical Writing Market Will Grow Nearly USD 9.4 Billion At A Rate Of 10.4% By 2032
Dental Biomaterial Market Valuation Expected To Hit USD 3.14 Billion By 2032
Ashwagandha Market Will Reach USD 1,187 Million By 2033 And Hit Around 10.9% CAGR
Cell Culture Market Outlook: Expected To Expand To USD 18.6 Billion Upholding A 12.4% CAGR
Editor Details
-
Company:
- Wired Release
- Website:
